Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) logo — company profile

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

Founded 2000 United States Irvine, United States 169 employees Debt Financing Fashion, Health Care +1

General Information

Company Name ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
Founded Year 2000
Location United States Irvine, United States
Employees 169
Industries Fashion, Health Care, Pharmaceutical
Funding Stage Debt Financing
Business Model B2B, B2C, D2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant). To contact ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant), visit bausch.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) compare?

A PDF of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

ISTA Pharmaceuticals, founded in 2000, emerged as a dynamic specialty pharmaceutical enterprise in the United States, with a focus on eye care and allergy treatments. It gained recognition as the fourth largest branded prescription eye care business in its market, substantiated by a robust U.S. sales force of over 165 representatives.

With a diversified product portfolio, ISTA Pharmaceuticals brought forth significant treatments such as BROMDAY™ for ocular inflammation, BEPREVE® for allergy-induced ocular itching, ISTALOL® for managing glaucoma, and VITRASE® as a pharmaceutical spreading agent. This portfolio underscored its innovation and client-focused strategies in the ophthalmic and allergy drug sectors.

In June 2012, ISTA was acquired by Bausch + Lomb, which was subsequently integrated into Valeant in July 2013. This acquisition positioned the company within larger pharmaceutical ecosystems, potentially enhancing its market reach and product development capabilities.

Services & Products

Manufacturing and Distribution of Contact Lenses
Development of Ophthalmic Pharmaceuticals
Retail of Eye Care Solutions
Supply of Lens Care Products
Distribution of Diagnostic Tools for Eye Health
Provision of Surgical Eye Care Solutions
Investments in Eye Health Research and Innovation

Target Customers

Eye Care Professionals Patients with Eye Health Needs Healthcare Providers Retailers of Eye Care Products Optometrists Ophthalmologists

No funding data available for ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) yet.

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) Alternatives & Competitors

View All Alternatives
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) vs
Sight360
Sight360 United States

Sight360 operates 28 ophthalmology, optometry and optical retail practices in the Greater Tampa Bay...

63 employees
Fashion, Health Care
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) vs
Hoya Vision Care
Hoya Vision Care Thailand

For the Visionaries

2821 employees
Design, Fashion
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) vs
Abbott
Abbott United States

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and bran...

IPO
152808 employees
Biotechnology, Health Care
Also compare with: ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) vs Bausch Health Companies Inc. Bausch Health Companies Inc. View all alternatives

FAQ About ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

ISTA Pharmaceuticals, Inc, was a rapidly growing specialty pharmaceutical company developing, marketing and selling products in the U.S. and Puerto Rico. It was the fourth largest branded prescription eye care business in the U.S. and had an emerging allergy drug franchise. Its products treated ocul...
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) was founded in 2000.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) is headquartered in Irvine, United States.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) operates in Fashion, Health Care and Pharmaceutical. Its customers include Eye Care Professionals, Patients with Eye Health Needs and Healthcare Providers.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has a B2B, B2C and D2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has approximately 169 employees.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) offers: Manufacturing and Distribution of Contact Lenses, Development of Ophthalmic Pharmaceuticals, Retail of Eye Care Solutions, Supply of Lens Care Products, Distribution of Diagnostic Tools for Eye Health, Provision of Surgical Eye Care Solutions, Investments in Eye Health Research and Innovation.
Top alternatives and competitors to ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) include Sight360, Hoya Vision Care, Abbott, Tablt Pharmacy (Acquired by Zeno Health), Gilead Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) and Sight360 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant), https://bouncewatch.com/company/ista-pharmaceuticals, updated 31 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout